SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision

🎯 Drug Targets

Browse 2 drug targets with druggability analysis, composite scores, and clinical context

2
Targets
0
High Druggability
0.65
Avg Score
15
Target Classes
Druggability Distribution
High: 0Medium: 2Low: 0Unknown: 0
Avg druggability score: 0.524
Clinical Pipeline
Approved: 2Phase III: 0Phase II: 0Phase I: 0Preclinical: 0
Total compounds: 5 · Approved: 4
Class All Classes Enzyme (35) Signaling Protein (25) Structural Protein (17) Protein (16) Gpcr (13) Ion Channel (12) Receptor (11) Transcription Factor (11) Ligand (10) Epigenetic Regulator (8) Transporter (8) Kinase (7) Other (4) Protease (4) Chaperone (4)
Druggability All Druggability Low (97) Medium (56) Undruggable (19) High (10) other (3)
Sort Score Druggability Gene A-Z Market Price
Filtered by: class=kinase, druggability=Medium — 2 results
PRKAA1 AMP-activated protein kinase catalytic subunit alp Approved
Kinase Medium Druggability
Score
0.67
Drug.
0.55
Safety
0.70
Drugs
2
Hyps
2
Papers
46
Small molecule activator of AMP-activated protein kinase
PDGFRB Platelet-derived growth factor receptor beta Approved
Kinase Medium Druggability
Score
0.63
Drug.
0.50
Safety
0.60
Drugs
3
Hyps
2
Papers
44
Small molecule inhibitor of receptor tyrosine kinase activity
Exchange | Dashboard